Paxman Q2: Nothing spectacular, but in the right direction - Redeye

Redeye provides an update following Paxman’s Q2 2025 report. We argue the report is decent, and the company’s solid long-term outlook remains intact. While the figures came in somewhat below our estimates, the overall direction of the business is unchanged. Based on the report, we have made some downward adjustments to our sales estimates, rendering slight changes to our fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/1123442/paxman-q2-nothing-spectacular-but-in-the-right-direction?utm_source=finwire&utm_medium=RSS